This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: The Hong Kong Polytechnic University. Active years: 2013-2016.
Company Filing History:
Years Active: 2013-2016
Title: Innovations of Sau Hing Chan in Anti-Cancer Research
Introduction
Sau Hing Chan is a prominent inventor based in Hong Kong, CN. She has made significant contributions to the field of anti-cancer research, holding a total of three patents. Her work focuses on developing quinoline derivatives that exhibit anticancer activities against various cancer cell lines.
Latest Patents
Chan's latest patents include "Quinoline derivatives as anti-cancer agents," which details quinoline derivatives showing anticancer activities against cancer cell lines of hepatocellular carcinoma (Hep3B), lung carcinoma (A549), and esophageal squamous cell carcinoma (HKESC-1, HKESC-4, and KYSE150). Another notable patent is "Method of making and administering quinoline derivatives as anti-cancer agents," which relates to methods of preparing quinoline derivative compounds and administering such compounds in the treatment of solid and non-solid tumors, particularly liver cancer.
Career Highlights
Chan is affiliated with The Hong Kong Polytechnic University, where she continues her research and development in the field of cancer treatment. Her innovative approaches have garnered attention in the scientific community.
Collaborations
Some of her notable coworkers include Johnny Cheuk-on Tang and Albert Sun-chi Chan, who have collaborated with her on various research projects.
Conclusion
Sau Hing Chan's work in developing quinoline derivatives as anti-cancer agents represents a significant advancement in cancer research. Her contributions are paving the way for new treatment options for patients suffering from various types of cancer.